273 related articles for article (PubMed ID: 6715398)
41. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
Kempson RL; Hendrickson MR
Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
[TBL] [Abstract][Full Text] [Related]
42. [MR Imaging of primary ovarian tumors with pathologic correlation].
Bouic-Pagès E; Perrochia H; Mérigeaud S; Giacalone PY; Taourel P
J Radiol; 2009; 90(7-8 Pt 1):787-802. PubMed ID: 19752784
[TBL] [Abstract][Full Text] [Related]
43. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
44. Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis.
Terada T
Int J Clin Exp Pathol; 2012; 5(9):924-7. PubMed ID: 23119109
[TBL] [Abstract][Full Text] [Related]
45. Proliferative serous tumors of the ovary. Histologic features and prognosis.
Katzenstein AL; Mazur MT; Morgan TE; Kao MS
Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
[TBL] [Abstract][Full Text] [Related]
46. [Ovarian cancer--modern approach to its origin and histogenesis].
Nowak-Markwitz E; Spaczyński M
Ginekol Pol; 2012 Jun; 83(6):454-7. PubMed ID: 22880466
[TBL] [Abstract][Full Text] [Related]
47. Tumor markers of epithelial ovarian neoplasms.
Khalifa MA; Sesterhenn IA
Int J Gynecol Pathol; 1990; 9(3):217-30. PubMed ID: 2197239
[TBL] [Abstract][Full Text] [Related]
48. [Immunohistochemical localization of estradiol in malignant epithelial tumors of the ovary].
Takamizawa M; Yaoi Y; Kumasaka T; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):359-66. PubMed ID: 3559322
[TBL] [Abstract][Full Text] [Related]
49. Study on the histogenesis of ovarian tumors--with special reference to five clinical cases with common epithelial tumors detected during the preclinical stage.
Tsukahara Y; Shiozawa I; Sakai Y; Ishii J; Iwai S; Fukuta T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):959-65. PubMed ID: 7108312
[TBL] [Abstract][Full Text] [Related]
50. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
51. Ovarian epithelial tumours of borderline malignancy: pathological features and current status.
Br J Obstet Gynaecol; 1983 Aug; 90(8):743-50. PubMed ID: 6309211
[No Abstract] [Full Text] [Related]
52. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
[TBL] [Abstract][Full Text] [Related]
53. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
54. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.
Lee KR; Scully RE
Am J Surg Pathol; 2000 Nov; 24(11):1447-64. PubMed ID: 11075847
[TBL] [Abstract][Full Text] [Related]
55. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
56. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
57. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
58. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors.
Gaytan F; Morales C; Barreiro ML; Jeffery P; Chopin LK; Herington AC; Casanueva FF; Aguilar E; Dieguez C; Tena-Sempere M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1798-804. PubMed ID: 15585554
[TBL] [Abstract][Full Text] [Related]
59. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.
Dubé V; Roy M; Plante M; Renaud MC; Têtu B
Int J Gynecol Pathol; 2005 Apr; 24(2):138-46. PubMed ID: 15782070
[TBL] [Abstract][Full Text] [Related]
60. [Histogenetic considerations on mucinous cystomas of the ovary based on histochemical and immunohistochemical findings].
Lapertosa G
Pathologica; 1989; 81(1074):381-401. PubMed ID: 2696922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]